NCT01579357View on ClinicalTrials.gov

Pharmacokinetics and Metabolic Activation of Capecitabine

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Metastatic Colorectal Cancer
Interventions
OTHER

blood samples

"Draw blood samples in week 1 (day 1 and day 5), in week 4 (day 1 and day 5) and in week 7 (day 1 and day 5).~day 1: pre dose, 30,60,90,120,150,180,240,300 and 360min day 5: pre dose, 30,60,90,120min"

Trial Locations (3)

1090

AKH Wien, Vienna

1100

Kaiser Franz Josef Spital, Vienna

5020

PMU Salzburg, Salzburg

All Listed Sponsors
lead

Arbeitsgemeinschaft medikamentoese Tumortherapie

OTHER

NCT01579357 - Pharmacokinetics and Metabolic Activation of Capecitabine | Biotech Hunter | Biotech Hunter